GrowBLOX Sciences Inc. (OTC:GBLX)Detailed Quote · Free Stock Analysis
GB Sciences, Inc. (GBLX) is a diverse vertically integrated cannabis company, focused on cultivation as well as biopharmaceutical research and development. The Company’s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about Growblox Sciences, Inc., go to: http://growblox.com.
- Why Cannabinoids Work Best Together
- GB Sciences Embraces Cannabinoid Complexities
- GB Sciences Files Patent Application for the Treatment of Chronic Arthritis, Crohn’s Disease, Inflammatory Bowel Disease, and Asthma…
- GB Sciences Resets: Licensed Cultivator and Biopharma
- GB Sciences (GBLX): A Grow Business with a Moonshot in Biopharma
Around the Web
- Why Cannabinoids Work Best Together — CFN Media
- GROWBLOX SCIENCES, INC. Financials
- GROWBLOX SCIENCES, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement
- GB Sciences Embraces Cannabinoid Complexities, Plus New Interview — CFN Media
- GB Sciences Files Patent Application for the Treatment of Chronic Arthritis, Crohn’s Disease, Inflammatory Bowel Disease, and Asthma; Proprietary Cannabinoid-Containing Complex Mixtures for the Treatment of Inflammatory Disorders
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.